Valneva SE - ESG Rating & Company Profile powered by AI
This page is a free Sustainability report covering Valneva SE. Browse to the bottom of the page for potential risks for Valneva SE based on industry, location and size. This analysis of Valneva SE was assembled by All Street Sevva using leading Cognitive Robots.
Valneva SE in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Valneva SE | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Valneva SE have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Valneva SE disclose current and historical energy intensity?
Sign up for free to unlockDoes Valneva SE report the average age of the workforce?
Sign up for free to unlockDoes Valneva SE reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Valneva SE disclose its ethnicity pay gap?
Sign up for free to unlockDoes Valneva SE disclose cybersecurity risks?
Sign up for free to unlockDoes Valneva SE offer flexible work?
Sign up for free to unlockDoes Valneva SE have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Valneva SE disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Valneva SE conduct supply chain audits?
Sign up for free to unlockDoes Valneva SE disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Valneva SE conduct 360 degree staff reviews?
Sign up for free to unlockDoes Valneva SE disclose the individual responsible for D&I?
Sign up for free to unlockDoes Valneva SE disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Valneva SE disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Valneva SE disclose water use targets?
Sign up for free to unlockDoes Valneva SE have careers partnerships with academic institutions?
Sign up for free to unlockDid Valneva SE have a product recall in the last two years?
Sign up for free to unlockDoes Valneva SE disclose incidents of discrimination?
Sign up for free to unlockDoes Valneva SE allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Valneva SE issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Valneva SE disclose parental leave metrics?
Sign up for free to unlockDoes Valneva SE disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Valneva SE disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Valneva SE disclose the pay ratio of women to men?
Sign up for free to unlockDoes Valneva SE support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Valneva SE disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Valneva SE reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Valneva SE involved in embryonic stem cell research?
Sign up for free to unlockDoes Valneva SE disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Valneva SE disclose its waste policy?
Sign up for free to unlockDoes Valneva SE report according to TCFD requirements?
Sign up for free to unlockDoes Valneva SE disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Valneva SE disclose energy use targets?
Sign up for free to unlockDoes Valneva SE disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Valneva SE have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Valneva SE
These potential risks are based on the size, segment and geographies of the company.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is headquartered in Saint-Herblain, France.